Kolexia
Bourgeois Hugues Oncologie médicale
Bourgeois Hugues
Oncologie médicale
Gcs Medecine Nucleaire Sarthe_et Siege
Le Mans, France
141 Activités
48 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs de l'ovaire Métastase tumorale Récidive tumorale locale Cellules tumorales circulantes Tumeurs du poumon Carcinome épithélial de l'ovaire Carcinomes Fatigue

Collaborateurs

Voir plus
Pierga Jean-Yves
Pierga Jean-Yves
Clcc Institut Curie, Paris, France
Lortholary Alain
Lortholary Alain
Alek Onco, Nantes, France
Denis Fabrice
Denis Fabrice
Gcs Medecine Nucleaire Sarthe_et Siege, Le Mans, France
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Pfizer
6 collaboration(s)
Dernière en 2021
Novartis
5 collaboration(s)
Dernière en 2022
Lilly
4 collaboration(s)
Dernière en 2022
Daiichi Sankyo
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence
Essai Clinique (Lilly)   29 février 2024
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast (Edinburgh, Scotland)   09 février 2024
CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
Essai Clinique (ARCAGY/ GINECO GROUP)   22 décembre 2023
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   21 décembre 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   06 novembre 2023
TAPAZ: A Randomized Phase II Study of Pazopanib and Weekly Paclitaxel in Patients With Platinum Resistant/Refractory Ovarian Cancer Who Relapse During Bevacizumab Maintenance
Essai Clinique (Novartis)   05 septembre 2023
Audit croisé des activités de pharmacie clinique entre deux centres hospitalo-universitaires : retour d’expérience d’une démarche stimulante
Le Pharmacien Clinicien   17 août 2023
The place of the relative at the time of the announcement of cancer progression: BABEL - a mixed-methods study.
Palliative & supportive care   26 juin 2023
SILENCE: Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide Chemotherapy
Essai Clinique (CHU Tours)   09 mai 2023
203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023